PEPT ETF
PEPT ETF
$27.09
REX Peptide ETF
AUM$3M
TER0.65%
Holdings35
See how much of PEPT you already own
See how much of PEPT you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
PEPT ETF Overview
PEPT ETF (REX Peptide ETF) is managed by REX Shares with $3.2M in net assets. PEPT expense ratio is 0.65%, holding 35 positions across sectors including Health Care, Materials. Inception date: 2026-10-14.
PEPT performance shows data across multiple time periods..
PEPT top holdings include Eli Lilly & Co (13.5%), Ascendis Pharma A/S (10.7%), Novo-Nordisk A/S-Spons Adr (9.9%), Insulet Corp (8.3%), Protagonist Therapeutics Inc (7.0%). Go to all PEPT holdings, PEPT sectors, or PEPT dividends.
PEPT can be compared against other funds. Use PEPT overlap to find shared positions, or PEPT vs another fund for a side-by-side view. PEPT alternatives are available via the screener, along with tax-loss harvesting opportunities.